Federal contract award
75F40123F19005
CLINICAL PHARMACOLOGY STUDIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | 75F40119D10032 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $6.0M |
| Current contract value | $6.0M |
| Potential contract value / ceiling | $6.0M |
| Start date | Sep 28, 2023 |
| Current end date | Mar 28, 2026 |
| Potential end date | Mar 28, 2026 |
| Latest award activity | Jan 7, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 7, 2025 | P00004 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO MARCH 28, 2026 |
| Sep 13, 2024 | P00003 | $1.0M | CLINICAL PHARMACOLOGY STUDIES TO ADDING FUNDING AND CHANGE ASSIGNED COR. |
| May 29, 2024 | P00002 | $0 | CLINICAL PHARMACOLOGY STUDIES |
| Feb 2, 2024 | P00001 | $0 | CLINICAL PHARMACOLOGY STUDIES |
| Sep 28, 2023 | 0 | $5.0M | CLINICAL PHARMACOLOGY STUDIES |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.